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Clinical Case Report
ABSTRACT
Hydrogen chloride is available commercially as an anhydrous gas or an aqueous solution, hydrochloric acid. Exposure 
to this gas has been associated with the development of reactive airways dysfunction syndrome. However, there are 
few published reports. A 37-year-old woman developed progressive bronchospasm and acute respiratory failure after 
cleaning an enclosed space with an unknown concentration of hydrochloric acid gas from a cleaning substance. She 
had no prior history of asthma or atopy. Severe bronchospasm developed, leading to hypoxemia and diffuse interstitial 
infiltrates, necessitating orotracheal intubation and admission to the intensive care unit. Asthma-like symptoms such as 
cough, wheezing, and dyspnea; requiring bronchodilators, and repeated hospitalizations are persistent a year after the 
accident. Pulmonary function testing showed mild airflow obstruction. 
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INTRODUCTION
Reactive airways dysfunction syndrome (RADS) is 
defined as acute and persistent respiratory symptoms 
and nonspecific bronchial hyperreactivity. It was first 
described by Brooks et al.1 to designate an asthma-
like condition that may develop following exposure 
to toxic gases. This syndrome appears shortly after 
exposure to the causative agent. It is characterized 
by increased non-allergic airway hyperreactivity and 
asthma-like symptoms in a subject with no history of 
asthma prior to the exposure. This syndrome can occur 
after exposure to a variety of toxic gases, including 
hydrochloric acid (HCl), ammonia, and hydrogen 
sulfide. Patients may persist symptomatic even after 
a single exposure to the toxic gas.2 This syndrome 
appears to have an equal male to female incidence.3
HCl is a non-flammable and colorless liquid with 
a strong, pungent odor commercialized as a chemical 
product component used to clean and disinfect 
swimming pools.4 When present at a concentration 
of 25% or more, it fumes in the air and becomes 
hydrogen chloride gas.5-7 Its high-water solubility 
allows for rapid dissolution on mucous membranes 
after inhalation, normally causing low systemic toxicity. 
High concentrations of HCl appear to saturate the 
buffering capacities of the nasal mucosa.6,8 Once HCl 
is absorbed into the mucous layers and membranes, 
it dissociates into hydrogen and chloride ions. 
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The hydrogen ions in contact with water produce 
hydronium ions, which rapidly react with organic 
molecules. That reaction is presumably responsible for 
the cellular injury.8,9 Meanwhile, the chloride ions are 
not sufficient to disturb the body’s electrolyte balance.8
Respiratory tract effects range from mild to 
moderate irritation at low concentrations (below 
100ppm). At higher concentrations, greater than 
500ppm, hydrogen chloride may cause tachypnea, 
shortness of breathing, chest tightness, wheeze/
stridor, dyspnea, and hypoxemia.9-11 Some severely 
exposed patients may develop acute respiratory distress 
syndrome from direct damage to the respiratory cells 
at the alveolar level or indirectly through inflammation 
mediators.10
This is a case report of a housekeeper exposed to 
high HCl fumes concentrations that evolved with acute 
respiratory distress syndrome suggestive of RADS, a 
still not fully-known disorder as to prognosis and its 
long-term effects.
CASE REPORT
A 37-year-old Caucasian woman arrived at the 
emergency facility with severe respiratory distress, 
associated with pleuritic pain and tachycardia. 
She denied any previous comorbidities or use of 
medications, except for a nine pack-year history of 
smoking. The patient reported she had applied a 
cleaning substance to wash a stone floor in a small and 
closed room. After a few minutes, she came back into 
this room to scrub the floor, and within a short period, 
she started to feel discomfort and dyspnea and left the 
room. Her dyspnea became progressively worse in the 
following two days when she decided to look for help.
On admission, the patient had a respiratory rate of 
thirty-eight breaths per minute and diffuse wheezing 
and rhonchi. She was treated with three fenoterol 
cycles (2.5mg) and ipratropium (0.5mg) inhalation. 
Meanwhile, we identified she had used a cleaning 
substance composed mainly of hydrochloric acid (HCl). 
Her exams showed leukocytosis of 23.06x106/L (RR: 
4.0 - 11.0 x106/L), composed of 88% neutrophils and 
1.3% eosinophils; a C-reactive protein of 256mg/L (RR: 
below 5 mg/L), and the arterial blood gas collected 
with 35% of the fraction of inspired oxygen (FiO2) had 
a pH of 7.34 (RR: 7.35 - 7.45), the partial pressure of 
Oxygen (PaO2) of 74.5mmHg (RR: 80 - 100 mmHg), 
the partial pressure of carbon dioxide of 35.8mmHg 
(RR: 35 - 45 mmHg), bicarbonate of 19.2mmol/L 
(RR: 21 - 28 mmol/L), base excess of -5.2mmol/L 
(RR: -3 - +3 mmol/L), oxygen saturation of 93.6% and 
a PaO2/FiO2 ratio of 212. The chest radiograph showed 
bilateral interstitial infiltrates (Figure 1). The patient 
met the Berlin criteria12 for acute respiratory distress 
syndrome. Despite treatment with bronchodilators 
and non-invasive ventilation, the patient became 
progressively worse, and her respiratory rate increased 
to 55 breaths per minute (bpm). Orotracheal 
intubation proceeded after ketamine, propofol, and 
succinylcholine, and she was set up on mechanical 
ventilation using parameters for lung protection with 
a low tidal volume. She was admitted to the intensive 
care unit and rapidly improved within the following 
twenty-four hours. A chest computed tomography (CT) 
scan showed diffuse asymmetric bilateral ground-glass 
opacities (Figure 2). She was successfully extubated the 
next day. Non-invasive ventilation was necessary for the 
first 4 hours after extubation due to bronchospasm. 
Methylprednisolone 60mg intravenously was given for 
the first two days, followed by prednisone 40mg orally 
for four days. The patient presented a dry cough and 
slight limitation of physical activity. She denied any 
other symptoms and was discharged.
We evaluated her one year after her index 
admission. In the first three months, the patient 
Figure 1. An anteroposterior chest radiograph at 
admission demonstrating bilateral interstitial infiltrates.
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continued to present shortness of breath, cough 
and wheezing, which could be triggered by minimal 
concentrations of irritants. Since her index admission, 
the patient had had four more admissions to the 
Emergency Department with respiratory complaints. 
Her clinical exam revealed no abnormality, and 
she stated she stopped smoking since the event. 
The spirometry data showed a forced expiratory 
volume in one second (FEV1)/ forced vital capacity 
(FVC) ratio of 0.79 (the predicted ratio for her was 
0.83); reduced FEV1 (77% of predicted) and FVC (81% 
of predicted). There was pulmonary flow gain after 
bronchodilator use (Delta FEV1= 260ml and 12%), 
demonstrating a positive response to bronchodilator 
and a mild obstructive ventilatory disorder. In the body 
plethysmography, the total lung capacity (TLC) was 
102% of predicted; and the thoracic gas volume (TGV) 
was 114% of predicted. The residual volume (RV) was 
at the upper limit of normality (137% of predicted), 
and there was a high RV/TLC value of 42 (135% 
of predicted), suggestive of air trapping. A normal 
diffusion capacity was seen (78% of predicted).
DISCUSSION
In the late 1800s and first half of the 1900s, 
human studies of hydrogen chloride (HCl) exposure-
response were performed in laboratories. Despite the 
remaining important data source, these reports are 
limited because the methodology used is less detailed 
than the current practice standards.8 There are no 
recent experimental human studies on HCl irritant 
effects except at very low concentrations (around 
1.8ppm), and the last available report was published 
in 1992. Ten asthmatic individuals (female/male) were 
exposed to 0.8 or 1.8 ppm HCl for forty-five minutes. 
Pulmonary function tests performed immediately 
after the exposure were compared to baseline levels. 
No exposure-related effects were observed in subjective 
symptoms or pulmonary function tests.13
Inhaled HCl may cause functional and morphologic 
respiratory tract injuries, depending on the exposure 
concentration and duration. The maximum bearable 
concentration in prolonged exposure of humans 
was reported as 10ppm; however, 10-50ppm for 
an exposure of a few hours is tolerable.8 Respiratory 
tract effects in laboratory animals range from mild to 
moderate irritation at low concentrations (less than 
100ppm) to nasal lesions at moderate concentrations 
(100-500 ppm) and pulmonary damage at high 
concentrations (greater than 500ppm), even with fairly 
short exposure periods. The concentration of 1000ppm 
and above cause unconsciousness, followed by death 
in thirty minutes to one hour.5,8
Because of its high-water solubility, most of 
the inhaled HCl gas is absorbed and neutralized by 
ammonia gas in the upper respiratory tract, explaining 
the occurrence of delayed respiratory irritation 
signs.6,8,9,13 In fact, little is known about the acid-base 
buffering capacity of respiratory mucous membranes 
and tissues.8
In a short-term study, three male baboons/groups 
were exposed for fifteen minutes to different HCl 
concentrations (0, 500, 5000, or 10000ppm).14 The 
Figure 2. Chest CT images (lung window) in medium (A) and apical (B) axial planes show bilateral ground-glass 
opacities with consolidation areas involving all pulmonary lobes.
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results indicated that the increased respiratory rate 
following the exposure was dose-related. Higher doses 
were associated with an acutely decreased partial 
pressure of oxygen (PaO2). Hypoxemia can be caused 
by ventilation-perfusion mismatches. Gas exchange can 
be impaired by interstitial and alveolar edema. Swelling 
of type I respiratory cells and endothelial cells, which 
corresponds to additional thickening of the alveolar-
capillary membrane, further impairs gas exchange. 
Arterial hypoxemia can also be worsened by alveoli 
collapse because of reduced surfactant production 
by the type II respiratory cells and surfactant proteins’ 
denaturation.10
We report a patient exposed to an unknown 
concentration of hydrogen chloride gas of a cleaning 
substance (HCl 22%) indoors in a room with no 
ventilation for an indefinite albeit short period. Despite 
being admitted in respiratory failure, her exposure 
occurred two days prior. She got progressively worse 
at home, complaining of dyspnea and persistent 
coughing. On arrival, the patient needed clinical 
support therapy focused on airway management, with 
supplemental oxygen and aerosolized bronchodilators, 
as needed.
β2 adrenergic agonist therapy is proposed as 
a means for relieving hydrochloric acid–induced 
bronchospasm. Some authorit ies recommend 
treatment with high doses of corticosteroids for 
patients with high-dose exposures, but this treatment’s 
value is questionable.4 Plausibly, corticosteroids could 
inhibit several of the involved pathophysiological 
processes such as (i) oxidative stress, (ii) increased 
lipid peroxidation, (iii) increased pro-inflammatory 
mediators, and/or (iv) changed cellular ultrastructures.10
In our case, the initial measures for bronchospasm 
were insufficient, and the patient required orotracheal 
intubation and mechanical ventilation. The patient 
had acute mild hypoxemia (PaO2/ fraction of inspired 
oxygen ratio between 200 and 300), bilateral opacities 
on chest radiography, not explained by cardiac 
failure or fluid overload. Thus, we considered acute 
respiratory distress syndrome diagnosis and adopted 
lung-protective ventilation strategies with low tidal 
volumes and limited plateau pressures.15 Some severely 
exposed patients may evolve with acute respiratory 
distress syndrome, and its full development takes time. 
Toxic reactive intermediates continue to be formed 
even after the exposure has ceased.10
The persistence of intermittent asthma symptoms 
after the accident, usually triggered by exposure 
to irritants, suggests Reactive Airway Dysfunction 
Syndrome (RADS). It is characterized by the appearance 
of asthma-like symptoms and an increase in nonspecific 
bronchial responsiveness after massive acute exposure 
to irritants. These individuals have a hyperreactive 
state, which may last from months to years, and 
persistent airway hyperresponsiveness is likely related, 
in this condition, to persistent epithelial damage, 
inflammation, and/or structural changes.16,17
The most probable pathogenesis of acute single 
exposure RADS and chronic irritant-induced asthma 
is bronchial or bronchiolar mucosa chemical irritation 
or burn. This is supported by biopsy studies in two 
initial case series by Brooks et al.18 How this mucosal 
inflammatory response leads to chronic and, in many 
cases, permanent airway dysfunction is not clear. 
The diagnosis of both acute and chronic irritant-induced 
asthma is based on history, supplemented by the 
measurement of the irritant’s level. It may be difficult to 
differentiate between chronic irritant-induced asthma 
and irritant-induced bronchoconstriction in patients 
with pre-existing asthma.19,20
The American College of Chest Physicians 
consensus criteria for the diagnosis of RADS was 
agreed in 1995,21 and are: (i) the absence of previous 
respiratory symptoms; (ii) the possibility for the patient 
to date the onset with a specific event; (iii) a high-level 
exposure to gas, (iv) smoke, (v) fume or vapor; (vi) the 
onset of symptoms occurring within a few hours after 
exposure with persistence for at least three months; 
(vii) asthma-like symptoms such as cough, wheezing, 
and dyspnea; (viii) pulmonary function tests that usually 
show airflow obstruction and increased response to 
methacholine; and (ix) no evidence of other pulmonary 
diseases.16
In this report, the patient was exposed to an 
environment containing an unknown concentration of 
HCl gas of a cleaning substance (HCl 22%). She had 
no personal or familial history of asthma or atopy, 
or respiratory symptoms prior to the HCl exposure, 
despite her smoker history. She also had no evidence of 
allergy or eosinophilia. The lung function test suggests 
mild obstructive ventilatory disorder responsive to 
bronchodilators. The sequence of events fits the 
pattern described in RADS. We had no histological 
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biopsies. This patient fulfills all the necessary criteria 
for RADS.
RADS is a controversial and poorly understood 
condition. Traditional treatment is the same as 
conventional asthma, despite evidence that patients 
with RADS are less responsive to β2 agonists.
3,16,17,22 The 
long-term outcome is not well documented, but if 
symptoms do not remit within six to twenty-four 
months, they are likely to remain persistent. In these 
cases, effective treatments are lacking, and the quality 
of life becomes impaired. Oral corticosteroids and 
bronchodilators started within the first three months 
of symptoms have had the most favorable outcomes.3
CONCLUSION
The current guidelines on human exposures to 
Hydrogen Chloride (HCl) depend on specialist opinion 
rather than evidence-based medicine. The data used 
for establishing the dose and the related threshold 
effects are limited, and it is still difficult to extrapolate 
to non-occupational settings and the general public. 
Well-designed studies are necessary to understand 
better the HCl exposure-response information, its 
health effects, and evidence-based treatments to 
reduce patient morbidity.
High-level exposure to HCl may result in severe 
acute symptoms and long term chronic persistent 
effects. This leads to increased health system cost 
readmissions and patient morbidity. Most Reactive 
Airway Dysfunction Syndrome (RADS) cases are 
recognized retrospectively, and they usually lack 
accurate assessment of the exposure intensity. Because 
there are few cases described in the literature, effective 
treatment guidance lacks, especially for those with 
persistent symptoms after six months. RADS may be a 
predictor of lung disease progression in those chronic 
patients and an independent risk factor for irreversible 
loss of lung function.
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